NCT05908175

Brief Summary

A spinal cord injury (SCI) disrupts the communication within the nervous system, leading to limitations in sensorimotor activities such as walking. Regular use of functional electrical stimulation (FES) can result in recovery of voluntary muscle control and muscle strength. Locomotor training with FES may be a promising method to improve gait function. The primary objective of this pilot study is to assess the feasibility and safety of an FES-assisted gait training intervention. Secondary objectives are to assess the effects of an FES-assisted gait training intervention on gait function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 8, 2023

Completed
2 days until next milestone

Study Start

First participant enrolled

May 10, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 18, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 7, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 7, 2024

Completed
Last Updated

December 18, 2024

Status Verified

December 1, 2024

Enrollment Period

1.1 years

First QC Date

May 8, 2023

Last Update Submit

December 13, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Feasibility of the intervention

    Self-administered questionnaires about the training sessions, preceived effect, applicability of FES and the experience with walking with FES.

    Assessed during week 11 during the post-intervention measurement.

  • Incidence of (Serious) Adverse Events [Safety of the Intervention]

    The total number of (serious) adverse events

    Assessed during week 1 to 10 for each FES-assisted gait training session (2x week) and in week 0, week 11 and week 21 (during the pre-, post- and follow-up measurements)

Secondary Outcomes (7)

  • Change in average and maximum treadmill walking speed

    Assessed during each FES-assisted gait training session (from week 1 until week 10, 2x a week)

  • Change in distance

    Assessed during each FES-assisted gait training session (from week 1 until week 10, 2x a week)

  • Change in average overground walking speed

    Assessed before and after the 10-weeks FES-assisted gait training intervention (during week 0 and week 11)

  • Change in muscle activity

    Assessed before and after the 10-weeks FES-assisted gait training intervention (during week 0 and week 11)

  • Change in step length

    Assessed before and after the 10-weeks FES-assisted gait training intervention (during week 0 and week 11)

  • +2 more secondary outcomes

Study Arms (1)

Intervention group

OTHER

FES-assisted gait training intervention group

Other: FES-assisted gait training

Interventions

The participants will walk with functional electrical stimulation (and possible body weight support) on a treadmill for 10 weeks, twice a week for 30 minutes.

Intervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Have a non-progressive incomplete SCI.
  • Have limited motor abilities in the lower extremities.
  • Be able to walk on a treadmill for 30 minutes (with body weight support).
  • Be able to perform the 10 meter walk test overground with assistive devices and/or support form the researcher/physician.
  • Have a stable medical condition.
  • Have had the SCI for at least a year.
  • Be at least 18 years of age.

You may not qualify if:

  • Cardiac arrhythmias or cardiac disease;
  • Flaccid paralysis.
  • Musculoskeletal dysfunction, uncured fractures, contractures, pressure injuries, or infections that could impede the intended training;
  • A history of severe autonomic dysreflexia assessed with the 'Autonomic standards assessment';
  • Neurostimulator, pacemaker, or other device that prevents the safe use of electrical stimulation present in the body;
  • Very high sensitivity to electrical stimulation, i.e., sensitivity threshold is reached before motor responses are observed in all target muscles;
  • Insufficient mastery of the Dutch language (speaking and reading);
  • Severe cognitive or communicative disorders;
  • Being or becoming pregnant during the study period;
  • Severe psychiatric illness or disorders (at the discretion of the treating rehabilitation physician);
  • Involved in another intervention study which may have an effect on the outcome measures of the present study;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stichting Reade

Amsterdam, 1054HW, Netherlands

Location

MeSH Terms

Conditions

Spinal Cord Injuries

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Thomas Janssen, Prof. Dr.

    Stichting Reade

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Pilot Study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 8, 2023

First Posted

June 18, 2023

Study Start

May 10, 2023

Primary Completion

June 7, 2024

Study Completion

June 7, 2024

Last Updated

December 18, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations